Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05732272
PHASE3
Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment
Sponsor: University of Kansas Medical Center
View on ClinicalTrials.gov
Summary
This study will evaluate the efficacy of extended bupropion(6 months) versus standard bupropion treatment (7 weeks) among African American daily smokers.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
500
Start Date
2023-02-28
Completion Date
2027-04-30
Last Updated
2026-02-23
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Bupropion
150 mg once daily for 3 days, then twice daily for the remainder of the treatment phase.
Locations (1)
University of Kansas Medical Center
Kansas City, Missouri, United States